A new trading day began on Tuesday, with Zai Lab Limited ADR (NASDAQ: ZLAB) stock price up 3.42% from the previous day of trading ,before settling in for the closing price of $15.49. ZLAB’s price has ranged from $15.24 to $40.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2095.12% over the last five years. Meanwhile, its annual earnings per share averaged 9.15%. With a float of $98.31 million, this company’s outstanding shares have now reached $98.72 million.
The firm has a total of 2175 workers. Let’s measure their productivity.
Zai Lab Limited ADR (ZLAB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.41%, while institutional ownership is 42.50%. The most recent insider transaction that took place on Apr 04 ’24, was worth 32,992. In this transaction an insider of this company sold 2,105 shares at a rate of $15.67, taking the stock ownership to the 51,800 shares. Before that another transaction happened on Apr 04 ’24, when Company’s insider sold 1,988 for $15.67, making the entire transaction worth $31,158. This insider now owns 28,684 shares in total.
Zai Lab Limited ADR (ZLAB) Recent Fiscal highlights
In its latest quarterly report, released on 12/30/2023, the company reported earnings of -$1 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.15% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Here are Zai Lab Limited ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.46, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.81 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.5 million was lower than the volume posted last year of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 29.31%. Additionally, its Average True Range was 0.88.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 4.88%, which indicates a significant decrease from 27.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.54% in the past 14 days, which was lower than the 57.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.04, while its 200-day Moving Average is $24.47. Now, the first resistance to watch is $16.23. This is followed by the second major resistance level at $16.43. The third major resistance level sits at $16.74. If the price goes on to break the first support level at $15.72, it is likely to go to the next support level at $15.41. Now, if the price goes above the second support level, the third support stands at $15.21.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
With a market capitalization of 1.58 billion, the company has a total of 99,209K Shares Outstanding. Currently, annual sales are 266,720 K while annual income is -334,620 K. The company’s previous quarter sales were 65,830 K while its latest quarter income was -95,430 K.
